Vaccinal Effect of HBsAg Monoclonal Ab VIR-3434 in Chronic Hepatitis B Infection [VISION]

Abroad (travel likely)RecruitingPHASE2

Conditions

Hepatitis B, Chronic

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

University Health Network, Toronto, Ontario, Canada
Contact: Study coordinator (Jordan Feld) · jordan.feld@uhn.ca · 416-340-4584
Contact: Study coordinator (Jiayun Chen) · jiayun.chen@uhn.ca · 416-340-4800

Study leads

Jordan Feld, MD
Principal Investigator
University Health Network, Toronto

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Phase 2 Study of AHB-137 in HBeAg Negative Chronic Hepatitis B (CHB) Participants in Asia Pacific Region

Hepatitis B, Chronic

Abroad (travel likely)RecruitingPHASE2

Fitzroy, Australia · Hong Kong, China

Evaluation of Patients With Liver Disease

Hepatitis D · Hepatitis C · Hepatitis B

Abroad (travel likely)Recruiting

Bethesda, United States

Real World Assessment of People Living With Chronic Hepatitis B in Australia

Hepatitis B

Abroad (travel likely)Recruiting

Sydney, Australia · Sydney, Australia

Three Types of Nucleotide/Nucleoside Analogues Treatment in HBV Related ACLF

Hepatitis B · Acute-On-Chronic Liver Failure

Abroad (travel likely)Recruiting

Guangzhou, China